Abstract:Abstract The NAD+-dependent deacetylase Sirt1 is known to modulate metabolism, inflammation, and aging. It has been reported that Sirt1 regulates differentiation and function of innate immune cells and T cells. However, the role of Sirt1 in B cell functions has not been well studied. The present study aimed to determine the role of Sirt1 in antigen presentation function of B cells. First, we investigated the effects of Sirt1 activator/inhibitor and Sirt1 deficiency on expression of major components (Ii, DM, DO, and MHC II) of the MHC II antigen presentation pathway in B cells, and we determined whether antigen presentation function of B cells is dependent on Sirt1 using an experiment regarding CD4+ OT-II T cell responses to OVA-pulsed Sirt1-deficient B cells or OVA-pulsed Sirt1 activator/inhibitor-stimulated B cells in vitro co-culture. Expression of all the components in B cells and CD4+ OT-II T differentiation to CD4+TNF-α+ (Th1), CD4+IL-17+ (Th17), and CD4+IL-21+ (Tfh) cells were diminished in the case of Sirt1 inhibitor-treated B cells or Sirt1-deficient B cells, while Sirt1 activator increased the expression and the differentiation. Next, we found that Sirt1 deacetylates CIITA, a key transcription factor of transcription of the major components in the MHC II antigen presentation pathway, in B cells. In addition, we revealed that Sirt1 is required for CIITA expression. Taken together, we conclude that Sirt1 is essential for antigen presentation by B cells, and this might be caused by induction of CIITA expression and deacetylation of CIITA. Supported by grants from NRF (2016R1D1A1B04935588, 2017R1A6A1A03015713)

Sirt1 is responsible for antigen presentation in B cells through induction of CIITA expression and CIITA deacetylation